Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/112304

In Collections

This item can be found in the following collections:

Taylor, P.; Keystone, E.C.; Heijde, D. van der; Tanaka, Y.; Ishii, T.; Emoto, K.; ... ; Larsson, E. (2016)

Baricitinib vs. placebo or adalimumab in patients with active rheumatoid arthritis and an inadequate response to background methotrexate therapy: results of a phase 3 study

Article / Letter to editor
All authors
Taylor, P.; Keystone, E.C.; Heijde, D. van der; Tanaka, Y.; Ishii, T.; Emoto, K.; Yang, L.; Arora, V.; Gaich, C.; Rooney, T.; Schlichting, D.; Macias, W.L.; Bono, S. de; Weinblatt, M.E.; Larsson, E.
Date
2016-12-31
Journal
Scandinavian Journal of Rheumatology
Volume
45
Pages
8 - 8